EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing

Fen Guo iD, Ruby Liu, Yinghong Pan iD, Mary Colasanto, Christin Collins, Madhuri Hegde iD

Human Mutation · 2024

DOI: 10.1155/2024/9115364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2024. Verfasst von Fen Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Revvity Omics, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Genetic Testing, Whole Genome Sequencing, Genetic Diseases, Inborn. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advancements in the next-generation sequencing have illuminated the occurrence of multiple genetic diagnoses (MGD). While exome sequencing has provided insights, genome sequencing (GS), the most comprehensive diagnostic tool, remains underexplored for studying MGD prevalence. We retrospectively analyzed 1487 pediatric cases from our laboratory, employing GS to investigate the incidence of single definitive genetic diagnosis (SDD) and MGD in children suspected of having a genetic disease. Of these patients, 273 received at least one definitive diagnosis, including 245 with SDD (16.5%) and 28 with MGD (1.9%). Diagnostic yield was consistent across genders and unaffected by previous testing in SDD cases. Notably, prior testing significantly increased the diagnostic yield in MGD cases to 2.7% overall and 14.4% among diagnosed cases, compared to 1.1% for those with GS as a first-tier test. Age was a significant factor in diagnostic outcome for both SDD and MGD cases with neonates showing the highest diagnostic yield of 24.5% in SDD and a notably higher yield in MGD at 4.9%, representing 16.7% of the diagnosed cases. Of the 28 MGD cases, 17 exhibited distinct phenotypes, 9 had overlapping features, and 2 presented a mix, underscoring the genetic and phenotypic heterogeneity within this group. This study is the first to exclusively use GS to assess MGD prevalence. Our findings highlight the complexity of rare diseases and emphasize the importance of comprehensive, genome-level diagnostics. Clinicians must ensure that diagnoses fully account for the observed phenotypes to inform optimal therapeutic strategies and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingWhole Genome SequencingGenetic Diseases, InbornHumansMaleFemaleChildChild, PreschoolInfantInfant, NewbornHigh-Throughput Nucleotide SequencingRetrospective StudiesAdolescentGenome, HumanPhenotype

Autor:innen und Institutionen

  • Revvity Omics, Pittsburgh, Pennsylvania, USA.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Fen Guo, Yinghong Pan, Madhuri Hegde

Zitieren

APA

Guo, F., Liu, R., Pan, Y., Colasanto, M., Collins, C., & Hegde, M. (2024). Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing. Human Mutation. https://doi.org/10.1155/2024/9115364

Vancouver

Guo F, Liu R, Pan Y, Colasanto M, Collins C, Hegde M. Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing. Human Mutation. 2024. doi:10.1155/2024/9115364

BibTeX
@article{Guo2024,
  author = {Guo, Fen and Liu, Ruby and Pan, Yinghong and Colasanto, Mary and Collins, Christin and Hegde, Madhuri},
  title = {Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing},
  journal = {Human Mutation},
  year = {2024},
  doi = {10.1155/2024/9115364}
}
Kostenlos starten →